Navigation Links
Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results
Date:1/25/2011

NEW BRUNSWICK, N.J., Jan. 25, 2011 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%. Worldwide sales for the full-year 2010 were $61.6 billion, a decrease of 0.5% versus 2009. Operational sales declined 1.3% and the positive impact of currency was 0.8%.  Domestic sales declined 4.7%, while international sales increased 3.6%, reflecting operational growth of 1.9% and a positive currency impact of 1.7%.

Net earnings and diluted earnings per share for the fourth quarter of 2010 were $1.9 billion and $0.70 respectively. Fourth-quarter 2010 net earnings included after-tax charges of $922 million representing the net impact of litigation settlements, product liability expense and costs associated with the DePuy ASR® Hip recall. Fourth-quarter 2009 net earnings included an after-tax restructuring charge of $852 million and an after-tax gain of $212 million representing the net impact of litigation settlements. Excluding these special items, net earnings for the current quarter were $2.9 billion and diluted earnings per share were $1.03, representing increases of 0.6% and 1.0%, respectively, as compared to the same period in 2009.*

Net earnings and diluted earnings per share for the full-year 2010 were $13.3 billion and $4.78, respectively. Full-year 2010 net earnings included an after-tax gain of $55 million representing the net impact of litigation settlements, product liability expense and costs associated with the DePuy ASR® Hip recall. Full-year 2009 net earnings included an after-tax restr
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
2. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
3. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
4. Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee
5. Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer
6. Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Pharmaceutical Business
7. Two-Time Super Bowl Champion Coach & Sports Broadcaster Jimmy Johnson Laughs About His Notoriety in New ExtenZe Spots from Inter/Media Advertising
8. Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnsons Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
9. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
10. Johnson & Johnson Completes Acquisition of Micrus Endovascular
11. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Lilly and Company (NYSE: LLY ) announced today the ... up to $1.6 billion aggregate principal amount of certain of ... tendered, and did not validly withdraw, their notes on or ... time, on May 27, 2015 (the early tender date), and ... receive the total consideration. The total consideration for each series ...
(Date:5/28/2015)... VANCOUVER and HOUSTON , May ... "Company") (TSX-V: EPI) today reported financial results for the second ... Amounts, unless specified otherwise, are expressed in Canadian dollars and ... Summary Results ESSA recorded a net ... six months ended March 31, 2015 (Q2-2015), compared to a ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ...  to their offering.       ... or gene silencing involves the use of ... cell, this material is processed into short ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
... 2011 Dynatronics Corporation (NASDAQ: DYNT ) today announced ... 2011. Sales for the quarter ended June 30, 2011 ... ended June 30, 2010. Sales for the year ended June 30, ... the prior year. Net income for the quarter ...
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... subsidiary, Valeant International (Barbados) SRL, has received notice that ... oral bile acid sequestrant for hypercholesterolemia, has been approved ... "Cardiovascular Disease is the cause of one in ...
Cached Medicine Technology:Dynatronics Announces Fourth Quarter and Year-end Results 2Dynatronics Announces Fourth Quarter and Year-end Results 3Dynatronics Announces Fourth Quarter and Year-end Results 4Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada 2Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada 3Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada 4
(Date:5/29/2015)... 2015 Abington Hospital – Jefferson ... first hospitals in the nation to join the ... practices and work toward achieving the Baby-Friendly USA© ... focusing on maternity care practices leading to Baby-Friendly ... and Prevention, EMPower is aimed at increasing breastfeeding ...
(Date:5/29/2015)... can mark one more item off her bucket list: skydiving. ... community is the oldest woman to have flown at an indoor ... she exclaimed. “I’ve always wanted to jump from an airplane ... would be ok.” , “We put on nylon coveralls, helmets, and ... “I don’t remember it being noisy, but the wind was blowing ...
(Date:5/29/2015)... Carolina (PRWEB) May 29, 2015 Red ... that the newest Red Hot & Blue restaurant at 525 ... on Thursday, May 7, 2015. “The Red Hot & Blue ... for 18 years, but we have moved to a new ... now in the middle of all the activities on the ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... unit have reached a confidential Risperdal lawsuit ( ... allegedly developed gynecomastia due to his use of ... case had been selected for the third bellwether ... a mass tort litigation underway in Pennsylvania’s Philadelphia ...
(Date:5/29/2015)... 29, 2015 World Patent Marketing, a ... that it has signed a 10 year licensing agreement ... aims to let people learn about any topic and ... , "This is an exciting day for World Patent ... J. Cooper, CEO and Creative Director of World Patent ...
Breaking Medicine News(10 mins):Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2Health News:Indoor Skydiving Brings Thrills to Seniors 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5
... ... International, a global multi-level marketing company, promotes launch of business operations in Ukraine. ... Kyiv, Ukraine (PRWEB) June ... On May 30th, Sisel Founder and Chairman Tom Mower Sr. was in the Ukrainian capital ...
... After months of ... online buying a simple, easy one-stop shopping experience. , ... (PRWEB) June 5, 2010 -- With online shopping growing in popularity, ... arrangements and payment procedures that it is easy to get confused, which can lead to ...
... new research that will be presented on Saturday, June 5, ... Dental Sleep Medicine, the majority of U.S. dental schools have ... which affect more than 70 million adults in the U.S. ... Angeles (UCLA) School of Dentistry surveyed each of the 58 ...
... be presented on Saturday, June 5, at the 19th Annual ... may help dentists predict oral appliance therapy success in sleep ... the nasal cavity. The tip of the scope is placed ... has been shown to be a safe and effective treatment ...
... to new research that will receive the Graduate ... the 19th Annual Meeting of the American Academy ... screen for sleep-disordered breathing (SDB) in a pediatric ... resistance syndrome, and snoring. The researchers evaluated ...
... ... Refrigerated Vacuum Pak or Modified Atmosphere Packaged Raw Fish and Fishery Product”, or Import ... or vacuum packed, raw seafood into the US. , ... (Vocus) June 7, 2010 -- “Detention Without Physical ...
Cached Medicine News:Health News:SISEL International Holds Successful Launch Events In Ukraine 2Health News:SISEL International Holds Successful Launch Events In Ukraine 3Health News:BestMassage.com Launches Its Brand New Customer-Focused Website 2Health News:US dental schools leave graduates unprepared to screen for sleep disorders 2Health News:Nasendoscopy proves useful in predicting treatment success in sleep apnea patients 2Health News:Questionnaires help dentists screen for sleep-disordered breathing in children 2Health News:FDA Issues Global Raw Packaged Seafood Import Alert: FDAImports.com Reports Numerous International Firms Impacted 2Health News:FDA Issues Global Raw Packaged Seafood Import Alert: FDAImports.com Reports Numerous International Firms Impacted 3
... ADVANCE Rapid HIV-1/2 Antibody ... qualitative immunoassay to detect ... Virus Type 1 (HIV-1) ... in oral fluid, fingerstick ...
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple...
Standard Trephine...
Coronet Vacuum Trephine - All metal, ergonomic design and ultra sharp blade with cross hairs....
Medicine Products: